187 related articles for article (PubMed ID: 21736478)
1. Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells.
Timmins NE; Athanasas S; Günther M; Buntine P; Nielsen LK
Tissue Eng Part C Methods; 2011 Nov; 17(11):1131-7. PubMed ID: 21736478
[TBL] [Abstract][Full Text] [Related]
2. Manufactured RBC--rivers of blood, or an oasis in the desert?
Timmins NE; Nielsen LK
Biotechnol Adv; 2011; 29(6):661-6. PubMed ID: 21609758
[TBL] [Abstract][Full Text] [Related]
3. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
[TBL] [Abstract][Full Text] [Related]
5. In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems.
Dorn I; Lazar-Karsten P; Boie S; Ribbat J; Hartwig D; Driller B; Kirchner H; Schlenke P
Transfusion; 2008 Jun; 48(6):1122-32. PubMed ID: 18298595
[TBL] [Abstract][Full Text] [Related]
6. Stem cells--a source of adult red blood cells for transfusion purposes: present and future.
Douay L; Lapillonne H; Turhan AG
Crit Care Clin; 2009 Apr; 25(2):383-98, Table of Contents. PubMed ID: 19341915
[TBL] [Abstract][Full Text] [Related]
7. Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion.
Andrade PZ; da Silva CL; dos Santos F; Almeida-Porada G; Cabral JM
J Cell Biochem; 2011 Jul; 112(7):1822-31. PubMed ID: 21400571
[TBL] [Abstract][Full Text] [Related]
8. [In vitro generation of mature and functional human red blood cells: a model with multidisciplinary perspectives].
Douay L; Giarratana MC
Bull Acad Natl Med; 2005 May; 189(5):903-13; discussion 914-5. PubMed ID: 16433462
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
Nagler A; Peacock M; Tantoco M; Lamons D; Okarma TB; Okrongly DA
Exp Hematol; 1994 Nov; 22(12):1134-40. PubMed ID: 7523166
[TBL] [Abstract][Full Text] [Related]
10. Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells.
Timmins NE; Palfreyman E; Marturana F; Dietmair S; Luikenga S; Lopez G; Fung YL; Minchinton R; Nielsen LK
Biotechnol Bioeng; 2009 Nov; 104(4):832-40. PubMed ID: 19591208
[TBL] [Abstract][Full Text] [Related]
11. Blood cell manufacture: current methods and future challenges.
Timmins NE; Nielsen LK
Trends Biotechnol; 2009 Jul; 27(7):415-22. PubMed ID: 19500866
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo generation of human red blood cells: a new advance in stem cell engineering.
Douay L; Giarratana MC
Methods Mol Biol; 2009; 482():127-40. PubMed ID: 19089353
[TBL] [Abstract][Full Text] [Related]
13. A closed system for the clinical banking of umbilical cord blood.
Adami V; Malangone W; Falasca E; Marini L; Risso A; Crini S; Toniutti E; Passoni Ferraro E; Del Frate G; Pittino M; Biffoni F; Rinaldi C; Degrassi A
Blood Cells Mol Dis; 2005; 35(3):389-97. PubMed ID: 16112591
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells.
Giarratana MC; Kobari L; Lapillonne H; Chalmers D; Kiger L; Cynober T; Marden MC; Wajcman H; Douay L
Nat Biotechnol; 2005 Jan; 23(1):69-74. PubMed ID: 15619619
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel.
Liu Y; Liu T; Fan X; Ma X; Cui Z
J Biotechnol; 2006 Jul; 124(3):592-601. PubMed ID: 16513201
[TBL] [Abstract][Full Text] [Related]
16. [The investigation of ex-vivo expansion of hematopoietic stem/progenitor cells].
Fan X; Bao C; Liu Y; Liu T; Sun X; Ge D; Ma X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):870-5. PubMed ID: 17899763
[TBL] [Abstract][Full Text] [Related]
17. Bioreactor for blood product production.
Doran MR; Aird IA; Marturana F; Timmins N; Atkinson K; Nielsen LK
Cell Transplant; 2012; 21(6):1235-44. PubMed ID: 22405378
[TBL] [Abstract][Full Text] [Related]
18. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo.
Neildez-Nguyen TM; Wajcman H; Marden MC; Bensidhoum M; Moncollin V; Giarratana MC; Kobari L; Thierry D; Douay L
Nat Biotechnol; 2002 May; 20(5):467-72. PubMed ID: 11981559
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO "Pluricell System".
Astori G; Adami V; Mambrini G; Bigi L; Cilli M; Facchini A; Falasca E; Malangone W; Panzani I; Degrassi A
Bone Marrow Transplant; 2005 Jun; 35(11):1101-6. PubMed ID: 15821764
[TBL] [Abstract][Full Text] [Related]
20. Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer.
Baek EJ; Kim HS; Kim JH; Kim NJ; Kim HO
Transfusion; 2009 Nov; 49(11):2285-95. PubMed ID: 19602217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
